Company facts: Royal PTT Nederland (KPN)

Article Abstract:

Royal PTT Nederland (KPN) is a privatized Dutch telecoms utility which has kept its postal operations. The company is seking to boost efficiency and and reported strong profits from its postal arm, but a rise in the cost of paper has affected direct mail activities. Telephony activities have been boosted by increased usage of mobile phones. Competition is reducting the price of international calls. The telecommunications industry is growing especially mobile telecommunications.

Royal PTT Nederland N.V.

---

An ideal candidate

Article Abstract:

The United Kingdom government is happy to continue with privatizations, and the Post Office is a possible candidate. The government seems to have decided against full privatization, but sees greater freedom as necessary for the Post Office. There is increased competition from European postal services, e-mail, fax, and pivate courier services. The Post Office is setting up alliances, but needs to be able to reinvest profits rather than paying them to the Treasury.

United Kingdom, Regulation and Administration of Communications, Electric, Gas, and Other Utilities, U.S. Postal Service, Postal Regulations, Planning, Post Office, United Kingdom. Post Office

---

Company facts: AT and T

Article Abstract:

AT and T plans to split into three companies dealing with computing, telecoms equipment and telecoms services. The equipment division should perform well due to a rise in infrastructure investment. The company should also benefit from an expansion of telecommunications services in the US but will face competition from sources such as cable companies. AT and T is using partnerships to penetrate overseas markets opened by liberalization.

Telecommunications Equipment, Communications Equipment Manufacturing, T, Telecommunications systems, American Telephone and Telegraph Co.

Similar abstracts:

• Abstracts: Company facts: Danone. GrandMet spices up its act
• Abstracts: Company facts: Time Warner. Sunny prospects. Flextech
• Abstracts: City's faith in Glaxo. Can SB cope on its own? Merck: premium rating

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.